Nardostachys jatamansi DC Extract Alleviates Insulin Resistance and Regulates Glucose Metabolism in C57BL/KsJ-db/db Mice Through the AMP-Activated Protein Kinase Signaling Pathway

Journal of Medicinal Food

Volumn 21, Issue 4, 2018, Pages 324-331

  You, Han Nwi ^a   Park, Mi Hwa ^b   Hwang, Sung Yeoun ^c   Han, Ji Sook ^a  

^a Pusan National University   (South Korea)

^b Silla University   (South Korea)

^c Korea Bio Medical Science Institute   (South Korea)

Author keywords

AMPK AS160 GLUT4 pathway; C57BL KsJ db db mice; hyperglycemia; insulin sensitivity; Nardostachys jatamansi DC

Indexed keywords

ANTIDIABETIC AGENT; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; PROTEIN KINASE B; ROSIGLITAZONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VALERIANA JATAMANSI EXTRACT; LIPID;

AMPK SIGNALING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DB/DB MOUSE; DIABETES CONTROL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL; VALERIANA JATAMANSI; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; DRUG EFFECT; GLUCOSE TOLERANCE TEST; KNOCKOUT MOUSE; LIVER; METABOLISM; NARDOSTACHYS; PHOSPHORYLATION; PHYTOTHERAPY; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCONEOGENESIS; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPIDS; LIVER; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; NARDOSTACHYS; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; SIGNAL TRANSDUCTION;

EID: 85045194963     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2017.4015     Document Type: Article

References (43)

1. Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
2. Cerf ME: Beta cell dysfunction and insulin resistance. Front Endocrinol 2013;4:1-12.
3. Raptis SA, Dimitriadis GD: Oral hypoglycemic agents: Insulin secretagogues, alpha-glucosidase inhibitors and inuslin sensitizers. Exp Clin Endocrinol Diabetes 2001;109:265-287.
4. Hollander P: Anti-diabetes and anti-obesitymedications: Effects on weight in people with diabetes. Diabetes Spectr 2007;20:159-165.
5. Bagchi A, Oshima Y, Hikino H: Jatamols A and B: Sesquiterpenoids of Nardostachys jatamansi roots 1. Planta Med 1991;57:282-283.
6. Chatterji A, Prakashi SC: The treatise on Indian medicinal plants. In: National Institute of Science Communication, Vol.5 New Delhi, 1997, pp. 99-100.
7. Arora RB: Nardostachys jatamansi: A chemical, pharmacological and clinical appraisal. Spec Rep Ser Indian Counc Med Res 1965;51:1-117.
8. Lyle N, Bhattacharyya D, Sur TK, et al.: Stress modulating antioxidant effect of Nardostachys jatamansi. Indian J Biochem Biophys 2009;46:93-98.
9. Min DL, Park EJ: Effects of Nardostachys jatamansi on atopic dermatitis-like skin lesions. J Korean Orient Pediatr 2012;26: 13-24.
10. Bae GS, Park HJ, Kim DY, et al.: Nardostachys jatamansi protects against cerulean-induced acute pancreatitis. Pancreas 2010; 39:520-529.
11. Baek S, Choi JH, Ko SH, et al.: Antioxidant and antiinflammatory effect of Nardostachys chinesis in IFN-c/LPSstimulated peritoneal macrophage. Korean J Orient Physiol Pathol 2009;23:853-859.
12. Haffner SM, Miettinen H, Stern MP: The homeostasis model in the San Antonio heartstudy. Diabetes Care 1997;20:1087-1092.
13. Katz A, Nambi SS, Mather K, et al.: Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85: 2402-2410.
14. Hulcher FH, Oleson WH: Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 1973;14:625-631.
15. Sato T, Man ZW, Toide K, et al.: Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of noninsulin-dependent diabetes mellitus. FEBS Lett 1997;407:329-332.
16. Klip A, Ramlal T, Young DA, et al.: Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 1987;224:224-230.
17. Klip A, Ramlal T, Bilan PJ, et al.: Recruitment of GLUT-4 glucose transporters by insulin in diabetic rat skeletal muscle. Biochem Biophys Res Commun 1990;172:728-736.
18. Czoski-Murray C, Warren E, Chilcott J, et al.: Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: A systematic review and economic evaluation. Health Technol Assess 2004;8:1-91.
19. Fonseca V: Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am J Med 2003;115:42-48.
20. Nyenwe EA, Jerkins TW, Umpierrez GE, et al.: Management of type 2 diabetes: Evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 2011;60:1-23.
21. Sharon FS, Carla GT: Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp Biol Med 2001;226:43-51.
22. Taskinen MR: Diabetic dyslipidaemia: From basic research to clinical practice. Diabetologia 2003;46:733-749.
23. Larsen ML, Hørder M, Mogensen EF: Effect of long-term monitoring of glycosylated hemoglobin levels in insulindependent diabetes mellitus. N Engl J Med 1990;323:1021-1025.
24. Alhassane T, Xu XM: Flaxseed lignans: Source, biosynthesis, metabolism, antioxidant activity, bio-active components and health benefits. Compr Rev Food Sci Food Saf 2010;9:261-269.
25. Muniyappa R, Lee S, Chen H, et al.: Current approaches for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:15-26.
26. Dragan S, Andrica F, Serban MC, et al.: Polyphenols-rich natural products for treatment of diabetes. Curr Med Chem 2015;22:14-22.
27. Babujanarthanam R, Kavitha P, Pandian MR: Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocininduced diabetic tissues by altering glycolytic and gluconeogenic enzymes. Fundam Clin Pharmacol 2010;24:357-364.
28. Kwak CS, Kwak JS: Cell fractionation method of the rat liver. Keimyung Med J 1986;5:45-53.
29. Bonora E, Targher G, Alberiche M, et al.: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
30. Hrebicek J, Janout V, Malinciková J, et al.: Detection of insulin resistance by simple quantitative insulin senstivitiy check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002;87:144-147.
31. Fujiwara T, Yoshioka S, Yoshioka T, et al.: Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 1988;37:1549-1558.
32. Robinson C, Tamborlane WV, Maggs DG, et al.: Effect of insulin on glycerol production in obese adolescents. Am J Physiol 1998;274:737-743.
33. Park SA, Choi MS, Cho SY, et al.: Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci 2006;79:1207-1213.
34. Jung UJ, Baek NI, Chung HG, et al.: Effects of the ethanol extract of the roots of Brassica rapa on glucose and lipid metabolism in C57BL/KsJ-db/db mice. Clin Nutr 2008;27:158-167.
35. Gagnon J, Sheppard E, Anini Y, et al.: Metformin directly inhibits ghrelin secretion through AMP-activated protein kinase in rat primary gastric cells. Diabetes Obes Metab 2013;15:276-279.
36. Klip A: The many ways to regulate glucose transporter 4. Appl Physiol Nutr Metab 2009;34:481-487.
37. Abdul-Ghani MA, DeFronzo RA: Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol 2010;2010: 476279.
38. Osorio-Fuentealba C, Contreras-Ferrat AE, Altamirano F, et al.: Electrical stimuli release ATP to increase GLUT4 translocation and glucose uptake via PI3Kc-Akt-AS160 in skeletal muscle cells. Diabetes 2013;62:1519-1526.
39. Sano H, Kane S, Sano E, et al.: Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 2003;278:14599-14602.
40. Agius L: Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 2008;414:1-18.
41. Guo X, Li H, Xu H, et al.: Glycolysis in the control of blood glucose homeostasis. Acta Pharmacol Sinica B 2012;2:358-367.
42. Rui L: Energy metabolism in the liver. Compr Physiol 2014;4: 177-197.
43. Bechmann LP, Hannivoort RA, Gerken G, et al.: The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 2012;56:952-964.